Status:
UNKNOWN
Molecular Mediators of Nerve Injury Signaling
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Diabetes
Nerve Injury
Eligibility:
All Genders
18-80 years
Brief Summary
Specific proteins and other signaling molecules are increased and decreased following nerve injury. Some of these are important in producing pain or explaining why pain persists after traumatic nerve ...
Eligibility Criteria
Inclusion
- patients undergoing surgery where tissue removal is anticipated
Exclusion
- age younger than 18
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01437332
Start Date
September 1 2011
Last Update
September 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 31096